Article
iPS cell technology in regenerative medicine
1 Apr 2010
Abstract excerpt
The promise of treating human genetic and degenerative diseases through the application of pluripotent cell-based tissue engineering and regenerative medicine has come significantly closer to realization since the isolation of human embryonic stem (ES) cells. While the study of ES cells has greatly increased our fundamental understanding of pluripotency, technical and ethical limitations have been seemingly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
